{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T21:25:52Z","timestamp":1768253152365,"version":"3.49.0"},"reference-count":42,"publisher":"The Fukushima Society of Medical Science","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FJMS","Fukushima J. Med. Sci."],"published-print":{"date-parts":[[2023]]},"DOI":"10.5387\/fms.2022-41","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T22:10:52Z","timestamp":1680127852000},"page":"57-65","source":"Crossref","is-referenced-by-count":8,"title":["Four cases of pseudomyxoma peritonei with ovarian tumors at our hospital"],"prefix":"10.5387","volume":"69","author":[{"given":"Riho","family":"Yazawa","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Fukushima Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Yazawa","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Fukushima Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Fukushima Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Ohara","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Fukushima Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Osuka","sequence":"additional","affiliation":[{"name":"Department of Surgery, Fukushima Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3342","reference":[{"key":"1","unstructured":"1. Yonemura Y. Treatment system for pseudomyxoma peritonei. MHLW Grants-in-Aid for Scientific Research (Research on Intractable Diseases) Summary Report:Research on the frequency and pathogenesis of pseudomyxoma peritonei in Japan and the development of treatment methods (H24 - Refractory, etc. (intractable) - designated - 007) 2012 Summary and sub-report. http:\/\/pmp-jp.org\/images\/treat_system.pdf"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Moran B, Cecil T, Chandrakumaran K <i>et al<\/i>. The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy. Colorectal Dis, <b>17<\/b>:772-778, 2015.","DOI":"10.1111\/codi.12975"},{"key":"3","unstructured":"3. Kato A, Yazawa H, Mastuida H. Two cases of pseudomyxoma peritonei with ovarian tumors originating from mucinous tumors of ovary and appendix. Fukushima Medical Journal, <b>70<\/b>;7-18, 2022."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Acs G, Serous and mucinous borderline (low malignant potential) tumor of the ovary. Am J Clin Patho, <b>123<\/b>:S13-S57, 2005.","DOI":"10.1309\/J6PXXK1HQJAEBVPM"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Smeenk RM, Van Velthusysen MI, Verwaal VJ, <i>et al<\/i>. Appendiceal neoplasms and pseudomyxoma peritonei:a population based study. Eur J Surg Oncol, <b>34<\/b>:196-201, 2008.","DOI":"10.1016\/j.ejso.2007.04.002"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. McKenny JK, Soslow RA, Longacre TA. Ovarian mature teratoma with mucinous epithelial neoplasms:morphologic heterogenecity and association with pseudomyxoma peritonei, Am J Surg Pathol, <b>32<\/b>:645-655, 2008.","DOI":"10.1097\/PAS.0b013e31815b486d"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ronett BM, Kajdacsy-Balla A, Gilks CB <i>et al<\/i>. Mucinous borderline ovarian tumor:points of general agreement and criteria, and behavior. Hum Pathol, <b>35<\/b>:949-960, 2004.","DOI":"10.1016\/j.humpath.2004.03.006"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bendix F, Reimer A, Gastinger I, <i>et al<\/i>. Primary appendiceal carcinoma. Epidemiology, surgeryand survival:results of a Germanmulti center study, Eur J Surg Oncol, <b>36<\/b>:763-77, 2010.","DOI":"10.1016\/j.ejso.2010.05.025"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Lai CW, Yue CT, Chen JH. Mucinous cystadenocarcinoma of the appendix mimics acute appendicitis, Clin Gastroenterol Hepatol, <b>11<\/b>:e11, 2013","DOI":"10.1016\/j.cgh.2012.05.023"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. McGory M, Maggard M, KangH, <i>et al<\/i>. Malignancies of the appendix:beyond case series reports, Dis Colon Rectum, <b>48<\/b>:2264-2271, 2005.","DOI":"10.1007\/s10350-005-0196-4"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Shaib WL, Goodman M, Chen Z, <i>et al<\/i>. Incidence and survival of appendiceal mucinous neoplasm. A SEER analysis, Am J Clin Oncol, <b>40<\/b>;569-573, 2015.","DOI":"10.1097\/COC.0000000000000210"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Nuta OA, Quinto AAM, Municio AM, <i>et al<\/i>. Mucinous appendiceal neoplasms, diagnosis and surgical treatment. Gir Esp, <b>95<\/b>:321-327, 2017.","DOI":"10.1016\/j.cireng.2017.07.011"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Misdaraji J, Yantiss R, Graeme-Cook F, <i>et al<\/i>. Appendiceal mucinous neoplasm:controversial issues. Arch Pathol Lab Med, <b>134<\/b>:864-870, 2010.","DOI":"10.5858\/134.6.864"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ronnett BM, Zahn CM, Kurman RJ, <i>et al<\/i>. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomtosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to \u201cpseudomyxoma peritonei\u201d. Am J Surg Pathol, <b>19<\/b>:1390-1408, 1995.","DOI":"10.1097\/00000478-199512000-00006"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ronnett BM, Yan H, Kurman RJ, <i>et al<\/i>. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer, <b>92<\/b>:85-91, 2001.","DOI":"10.1002\/1097-0142(20010701)92:1<85::AID-CNCR1295>3.0.CO;2-R"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Syed Ali Rizvi, Wajahat Syed, Ravi Shergill. Approach to pseudomyxoma peritonei. World J Gastrointest Surg, <b>27<\/b>;10:49-56, 2018.","DOI":"10.4240\/wjgs.v10.i5.49"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Chirihan Ayadi, Amine Naggar, Hajar Andour, <i>et al<\/i>. Appendiceal mucocele with pseudomyxoma peritonei mimicking ovarian tumor with peritoneal carcinomatosis. Radiol Case Rep, <b>17<\/b>;3000-3004, 2022.","DOI":"10.1016\/j.radcr.2022.05.028"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Vahan Kepenekian, Amaniel Kefleyesus, David Keskin, <i>et al<\/i>. Cancers, <b>14<\/b>;4434, 2022.","DOI":"10.3390\/cancers14184434"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Chuaqui RF, Zhuang Z, Emmert-Buck MR, <i>et al<\/i>. Genetic analysis of synchronous mucinous tumors of the ovary and the appendix. Hum Pathol, <b>27<\/b>:165-171, 1996.","DOI":"10.1016\/S0046-8177(96)90370-6"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Lee KR, Scully RE. Mucinous tumors o the ovary;a clinicopathologic study of 196 borderline tumors ( of intestinal type) and carcinomas, including an evaluation of 11 cases with \u201cpseudomyxona peritonei\u201d. Am J Surg Pathol, <b>24<\/b>:1447-1464, 2000.","DOI":"10.1097\/00000478-200011000-00001"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Guo AT, Song X, Wei LX, <i>et al<\/i>. Histological origin of pseudomyxoma peritonei in Chinese women; Clinicopathology and immunohistochemistry. World Gastroenterol, <b>17<\/b>:3531-3537, 2011.","DOI":"10.3748\/wjg.v17.i30.3531"},{"key":"22","unstructured":"22. Zhou F, Chen X, Li Y, Huang L. Two independent primary mucinous tumors involving the appendix and ovary accompanied with acellular pseudomyxoma peritonei. Int J Ciln Exp Pathol, <b>8<\/b>:11831-11834, 2015."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Baratti D, Kusamura S, Nonaka D, <i>et al<\/i>. Pseudomyxoma peritonei:Biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg, <b>249<\/b>:243-249, 2009.","DOI":"10.1097\/SLA.0b013e31818eec64"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ronnet BM, Seidman JD. Mucinous tumor arising in ovarian mature cystic teratomas; relationship to the clinical syndrome of pseudomyxoma preitonei. Am J Surg Pathol, <b>27<\/b>:650-657, 2003.","DOI":"10.1097\/00000478-200305000-00008"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. McKenney JK, Soslow RA, Longacre TA. Ovarian mature teratomas with mucinous epithelial neoplasms:morphologic heterogeneity and association with pseudomyxoma peritonei. Am J Surg Pathol, <b>32<\/b>:645-655, 2008.","DOI":"10.1097\/PAS.0b013e31815b486d"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Stewart CJR, Tukamoto T, Cooke B, <i>et al<\/i>. Ovarian mucinous tumor arising in mature cystic teratoma and associated with pseudomyxoma pertonei: report of two cases and comparison with ovarian involvement by low-grade appendiceal mucinous tumors, Pathology, <b>38<\/b>:534-538, 2006.","DOI":"10.1080\/00313020601024078"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Saluja M, Kenwright DN, Keating JP. Pseudomyxoma peritonei arising from a mucinous borderline ovarian tumor:Case report and literature review. Aust NZ J Obstet Gynaecol, <b>50<\/b>:399-403, 2010.","DOI":"10.1111\/j.1479-828X.2010.01189.x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Sugarbaker PH. Pseudomyxoma pertonei. A cancer whose biology is characterized by a redistribution phenomen, Am Surg, <b>219<\/b>:109-111, 1994.","DOI":"10.1097\/00000658-199402000-00001"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Rouzbohmanvm M, Chetky R. Mucinous tumors of appendix and ovary:an overview and evaluation of current practice, J Clin pathol. <b>67<\/b>:193-197, 2014.","DOI":"10.1136\/jclinpath-2013-202023"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Sugarbaker PH, Ryan DP. Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treatperitoneal metastasis from colorectal cancer:standard of care or an experimental approach?, Lancet Oncol, <b>13<\/b>:e362-369, 2012.","DOI":"10.1016\/S1470-2045(12)70210-3"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Pablo CC, Esquivel J, Sugarbaker PH. Cytoreductive surgery and intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy, Clin Transl Oncol, <b>5<\/b>:192-198, 2003.","DOI":"10.1007\/BF02712401"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Sugarbaker PH. Cytoreeductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma pertionei syndrome, Eur J Surg Oncol, <b>27<\/b>:239-243, 2001.","DOI":"10.1053\/ejso.2000.1038"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Chua TC, Moran BJ, Sugarbaker PH, <i>et al<\/i>. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, J Clin Oncol, <b>30<\/b>:2449-2456, 2012.","DOI":"10.1200\/jco.2012.30.4_suppl.532"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Passot G, Bakrin N, Issac S, <i>et al<\/i>. Postoperative outcome of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies. Eur J Surg Oncol, <b>40<\/b>:957-962, 2014.","DOI":"10.1016\/j.ejso.2013.10.002"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Arjona-Sanchez A, Ruflan-Pena S, Aanchez-Hidalgo JM, <i>et al<\/i>. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (HIPC) by minimally invasive approach, an initial experience, World J Surg, <b>42<\/b>:3120-3124, 2018.","DOI":"10.1007\/s00268-018-4634-6"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Gough DB, Donohue JH, Schutt AJ <i>et al<\/i>. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach, Ann Surg, <b>219<\/b>:112-119, 1994.","DOI":"10.1097\/00000658-199402000-00002"},{"key":"37","unstructured":"37. Yonemura Y, Canbey E, Wakama S, Sako S, Ishibashi H, Hiraon M, Motoi S, <i>et al<\/i>. Analysis of treatment failure after complete cytoreductive surgery for peritoneal metastasis from appendiceal mucinous neoplasm at a n Japanese high volume center for peritoneal surface malignancy. Jpn Cancer Choemother, <b>46<\/b>(2);251-358, 2019."},{"key":"38","unstructured":"38. Papanton E, Ntatasis K, Kyziridis D, Kalakonas A, HristakisC, Tntes AA. Twenty-years\u2019 experience with dytoreductive surgrey (CRS) and hyperthermic intraperitoneal chemoteharpy (HIPEC) for pseudomyxoma peritone (PMP). JBUON, <b>26<\/b>;1647-1652, 2021."},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Yan TD, Black D, Savady R, <i>et al<\/i>. A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Am Surg Oncol, <b>14<\/b>:484-492, 2007.","DOI":"10.1245\/s10434-006-9182-x"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Smeenk RM, Verwaal VJ, Zoetmulder FA, Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei\u2014a report of 103 procedures. Eur J Surg Oncol, <b>32<\/b>:186-190, 2006.","DOI":"10.1016\/j.ejso.2005.08.009"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Mohamed F, Moran BJ, Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy:the importance of a learning curve. Cancer J, <b>15<\/b>:196-199, 2009.","DOI":"10.1097\/PPO.0b013e3181a58d56"},{"key":"42","unstructured":"42. Kitai T, Hirai T, Fujita T, <i>et al<\/i>. Survey on the incidence and management of pseudomyxoma peritonei in Japan. Jpn J cancer Chemother, <b>40<\/b>:1043-1048, 2013."}],"container-title":["FUKUSHIMA JOURNAL OF MEDICAL SCIENCE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/69\/1\/69_2022-41\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T04:57:54Z","timestamp":1680929874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/69\/1\/69_2022-41\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.5387\/fms.2022-41","relation":{},"ISSN":["0016-2590","2185-4610"],"issn-type":[{"value":"0016-2590","type":"print"},{"value":"2185-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"2022-41"}}